4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-020823
SVP, Chief Accounting Officer sold 7,711 shares at $9.12 ($70,324)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2026-03-23 | Sale 10b5-1 | −7,711 | $9.12 | $70,324 | 61,902 | D: show line 1 in the form |
| Open-market sales · 7,711 sh · avg $9.12 · $70,324 | |||||||
Loading xslF345X06/wk-form4_1774384534.xml…